4//SEC Filing
Piscitelli Dominic 4
Accession 0001415889-25-018128
CIK 0001796280other
Filed
Jun 23, 8:00 PM ET
Accepted
Jun 24, 6:33 PM ET
Size
8.3 KB
Accession
0001415889-25-018128
Insider Transaction Report
Form 4
Piscitelli Dominic
Chief Financial Officer
Transactions
- Sale
Common Stock
2025-06-24$10.50/sh−32,466$341,039→ 68,317 total - Sale
Common Stock
2025-06-23$10.00/sh−584$5,840→ 101,233 total - Sale
Common Stock
2025-06-23$10.01/sh−450$4,505→ 100,783 total
Footnotes (2)
- [F1]The sales reported were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 30, 2024.
- [F2]Represents the weighted average share price of an aggregate total of 32,466 shares sold in the price range of $10.34 to $10.80 by the Reporting Person. The Reporting Person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
Documents
Issuer
Oric Pharmaceuticals, Inc.
CIK 0001796280
Entity typeother
Related Parties
1- filerCIK 0001695028
Filing Metadata
- Form type
- 4
- Filed
- Jun 23, 8:00 PM ET
- Accepted
- Jun 24, 6:33 PM ET
- Size
- 8.3 KB